许多经普通途径给药的药物由于未修饰,不能够以有效的浓度作用于目的器官,或者由于易被代谢而不能维持有效的给药时间.人们已经尝试许多靶向药物载体与系统来解决这些问题.总结了近几年来生物主动靶向型高分子药物载体的研究进展.针对叶酸介导,生物素介导,以及其他常见官能团介导的药物载体,从载体的合成,细胞检测以及动物实验等进行概述.生物主动靶向型高分子药物载体可以有效提高药物的生物利用度,减少药物的毒副作用.
参考文献
| [1] | Greco F;Vicent MJ .Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.[J].Advanced drug delivery reviews,2009(13):1203-1213. |
| [2] | Julien Nicolas;Simona Mura;Davide Brambilla .Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery[J].Chemical Society Reviews,2013(3):1147-1235. |
| [3] | Jing F;Li D;Xu W et al.Transferrin-and folate-modified,double-targeted nanocarriers for gene delivery[J].Pharm Biol,2014,52(05):570. |
| [4] | Xiuli Hu;Shi Liu;Yubin Huang .Biodegradable Block Copolymer-Doxorubicin Conjugates via Different Linkages: Preparation, Characterization, and In Vitro Evaluation[J].Biomacromolecules,2010(8):2094-2102. |
| [5] | Cheng Yang;Hongli Zhao;Huihui Yuan;Ronghua Yu;Minbo Lan .Preparation and Characterization of Thermosensitive and Folate Functionalized Pluronic Micelles[J].Journal of nanoscience and nanotechnology,2013(10):6553-6559. |
| [6] | Zhang W;Shi Y;Chen Y;Ye J;Sha X;Fang X .Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors.[J].Biomaterials,2011(11):2894-2906. |
| [7] | Park EK;Kim SY;Lee SB;Lee YM .Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery[J].Journal of Controlled Release: Official Journal of the Controlled Release Society,2005(1/3):158-168. |
| [8] | Xiong, X.Y.;Gong, Y.C.;Li, Z.L.;Li, Y.P.;Guo, L. .Active targeting behaviors of biotinylated Pluronic/poly (lactic acid) nanoparticles in vitro through three-step biotin-avidin interaction[J].Journal of biomaterials science,2011(12):1607-1619. |
| [9] | Xiong,X.Y.;Guo,L.;Gong,Y.C.;Li,Z.L.;Li,Y.P.;Liu,Z.Y.;Zhou,M. .In vitro & in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction[J].European journal of pharmaceutical sciences,2012(5):537-544. |
| [10] | 潘弘,牛国琴,潘俊,陆伟跃.人鼠嵌合抗肿瘤细胞核单抗-空间稳定脂质体的制备及其体外靶向[J].药学学报,2006(06):506-512. |
| [11] | Pan H;Han LM;Chen W;Yao M;Lu WY .Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes[J].Journal of Controlled Release: Official Journal of the Controlled Release Society,2008(3):228-235. |
| [12] | Cheng C;Wei H;Shi BX;Cheng H;Li C;Gu ZW;Cheng SX;Zhang XZ;Zhuo RX .Biotinylated thermoresponsive micelle self-assembled from double-hydrophilic block copolymer for drug delivery and tumor target[J].Biomaterials,2008(4):497-505. |
| [13] | Medina LA;Calixto SM;Klipper R;Phillips WT;Goins B .Avidin/biotin-liposome system injected in the pleural space for drug delivery to mediastinal lymph nodes.[J].Journal of Pharmaceutical Sciences,2004(10):2595-2608. |
| [14] | Abouzeid A H;Patel N R;Sarisozen C et al.Transferrintargeted polymeric micelles co-loaded with curcumin and paclitaxel:Efficient killing of paclitaxel-resistant cancer cells[J].Pharmaceutical Research,2014,31(08):1938. |
| [15] | Sawant,R.R.;Jhaveri,A.M.;Koshkaryev,A.;Zhu,L.;Qureshi,F.;Torchilin,V.P. .Targeted transferrin-modified polymeric micelles: Enhanced efficacy in vitro and in vivo in ovarian carcinoma[J].Molecular pharmaceutics,2014(2):375-381. |
| [16] | Sudimack J;Lee R J .Targeted drug delivery via the folate receptor[J].Advanced Drug Delivery Reviews,2000,41(02):147. |
| [17] | Gabizon A;Shmeeda H;Horowitz AT;Zalipsky S .Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.[J].Advanced drug delivery reviews,2004(8):1177-1192. |
| [18] | Nukolova NV;Oberoi HS;Cohen SM;Kabanov AV;Bronich TK .Folate-decorated nanogels for targeted therapy of ovarian cancer.[J].Biomaterials,2011(23):5417-5426. |
| [19] | Xia C F;Zhang Y;Boado R J et al.Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology[J].Pharmaceutical Research,2007,24(12):2309. |
| [20] | Gasparri A;Moro M;Curnis F et al.Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models[J].CANCER RESEARCH,1999,59(12):2917. |
| [21] | Megumi Kawamoto;Masayuki Kohno;Tomohisa Horibe;Koji Kawakami .Immunogenicity and toxicity of transferrin receptor-targeted hybrid peptide as a potent anticancer agent.[J].Cancer Chemotherapy and Pharmacology,2013(3):799-807. |
| [22] | Kawamoto M;Horibe T;Kohno M et al.A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells[J].BMC Cancer,2011,11:359. |
| [23] | Xu,Q.;Liu,Y.;Su,S.;Li,W.;Chen,C.;Wu,Y. .Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles[J].Biomaterials,2012(5):1627-1639. |
| [24] | Simnick, A.J.;Amiram, M.;Liu, W.;Hanna, G.;Dewhirst, M.W.;Kontos, C.D.;Chilkoti, A. .In vivo tumor targeting by a NGR-decorated micelle of a recombinant diblock copolypeptide[J].Journal of Controlled Release: Official Journal of the Controlled Release Society,2011(2):144-151. |
| [25] | Farokhzad OC;Jon S;Khademhosseini A;Tran TN;Lavan DA;Langer R .Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells.[J].Cancer research,2004(21):7668-7672. |
| [26] | Farokhzad OC;Cheng JJ;Teply BA;Sherifi I;Jon S;Kantoff PW;Richie JP;Langer R .Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo[J].Proceedings of the National Academy of Sciences of the United States of America,2006(16):6315-6320. |
| [27] | Cheng J;Teply BA;Sherifi I;Sung J;Luther G;Gu FX;Levy-Nissenbaum E;Radovic-Moreno AF;Langer R;Farokhzad OC .Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.[J].Biomaterials,2007(5):869-876. |
上一张
下一张
上一张
下一张
计量
- 下载量()
- 访问量()
文章评分
- 您的评分：
-
10%
-
20%
-
30%
-
40%
-
50%